# A Real-world HCM-cohort Trial

> **NCT07638033** · — · NOT_YET_RECRUITING · sponsor: **Xijing Hospital** · enrollment: 3000 (estimated)

## Conditions studied

- Hypertrophic Cardiomyopathy (HCM)

## Interventions

- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT07638033
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-30
- **Primary completion:** 2030-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2026-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07638033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07638033, "A Real-world HCM-cohort Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07638033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*